(¿Â¶óÀÎ) 2020 ´ëÇÑÄ¡¸ÅÇÐȸ Ãß°è Çмú´ëȸ : 2020-11-14±³À°ÀÏÀÚ : 2020-11-14
±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À°
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ) 2020 ´ëÇÑÄ¡¸ÅÇÐȸ Ãß°è Çмú´ëȸ ÁÖÃÖ±â°ü : ´ëÇÑÄ¡¸ÅÇÐȸ
´ã´çÀÚ : À̼±¿µ
¿¬¶ôó : 02-587-7462
À̸ÞÀÏ :
secretkda@thedementia.co.kr ±³À°Á¾·ù : ½Å°æ°ú
Âü¼®¿¹»óÀοø : 400¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 8 ½Ã°£ 50ºÐ
¼¼ºÎ¼ö°·á : 70,000¿ø
ºñ°í Á¤È¸¿ø 3¸¸¿ø, ÀϹÝȸ¿ø 2¸¸¿ø, ºñȸ¿ø 7¸¸¿ø (¿Â/¿ÀÇÁ¶óÀÎ µ¿ÀÏ, ÇöÀåµî·Ï ¾øÀ½)
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 11¿ù 14ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ (Room A) 08:50~09:00 Opening remarks ÀÌÁØÈ«(°Ç°º¸Çè°ø´Ü Àϻ꺴¿ø)
±³À°½Ã°£ 11¿ù 14ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ (Room A) 09:00~09:20 Áª¹é½º/GV1001 °í¼ºÈ£(ÇѾçÀÇ´ë)
±³À°½Ã°£ 11¿ù 14ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ (Room A) 09:20~09:40 Aducanumab/GV-971 ¾çµ¿¿ø(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 11¿ù 14ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ (Room A) 09:40~10:10 Featured Posters ()
ÈÞ½Ä 11¿ù 14ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ (Room A) 10:10~10:30 Coffee Break ()
±³À°½Ã°£ 11¿ù 14ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ (Room A) 10:30~11:10 Neurodegenerative Disease and Cognition, Focusing on Chronic Traumatic Brain Injury and Vascular Injury Ann McKee(Boston University)
±³À°½Ã°£ 11¿ù 14ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ (Room A) 11:10~11:50 Perturbance of proteostasis, ribonucleostasis and neuroinflammation in neurodegenerative diseases ±è½ÂÇö(ÇѾçÀÇ´ë)
±âŸ 11¿ù 14ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ (Room A) 11:50~12:10 ÃÑȸ ()
½Ä»ç 11¿ù 14ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ (Room A) 12:10~13:00 Lunch ()
±³À°½Ã°£ 11¿ù 14ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ (Room A) 13:00~13:25 Neurovascular unit and its change in Alzheimer Á¤¿ë(KAIST)
±³À°½Ã°£ 11¿ù 14ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ (Room A) 13:25~13:50 Structural and functional imaging assessments of cerebral microvasculature Á¶ÇüÁØ(UNIST)
±³À°½Ã°£ 11¿ù 14ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ (Room A) 13:50~14:15 Vascular amyloid hypothesis ¼»ó¿ø(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 11¿ù 14ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ (Room A) 14:15~14:40 neuropathology for VCID ±èÀºÁÖ(ºÎ»êÀÇ´ë)
ÈÞ½Ä 11¿ù 14ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ (Room A) 14:40~15:00 Coffee Break ()
±³À°½Ã°£ 11¿ù 14ÀÏ ¿Â¶óÀÎ °Ô½Ã 15:00~16:00 Poster session ()
±³À°½Ã°£ 11¿ù 14ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ (Room A) 16:00~17:00 Oral session ()
±³À°½Ã°£ 11¿ù 14ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ (Room B) 13:00~13:25 Neglect syndrome in stroke À̺´È(»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 11¿ù 14ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ (Room B) 13:25~13:50 Aphasia syndrome in stroke ¹ÚÇý¿ø(¿¬´ë¼¼ºê¶õ½ºº´¿ø)
±³À°½Ã°£ 11¿ù 14ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ (Room B) 13:50~14:15 Áø·áÁöħ°ú ½Å·Ú: ÁÁÀº Áø·áÁöħ? ÀÌÀ¯°æ(´ëÇÑÀÇÇÐȸ ¼øõÇâ´ëº´¿ø)
±³À°½Ã°£ 11¿ù 14ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ (Room B) 14:15~14:40 ´ëÇÑÄ¡¸ÅÇÐȸÁø·áÁöħ°³¹ßÇöȲ¹ßÇ¥ ÀÌÁø»ê(°æÈñÀÇ´ë)
±³À°½Ã°£ 11¿ù 14ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ (Room B) 16:00~16:20 Optimal Brain Heath for Reducing Vascular Burden ÀÓÀ缺(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 11¿ù 14ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ (Room B) 16:20~16:40 VCI Preventive Trials ¹®¼Ò¿µ(¾ÆÁÖÀÇ´ë)
±³À°½Ã°£ 11¿ù 14ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ (Room B) 16:40~17:00 Antiplatelet agents in cognitive disorders ÃÖ¼ºÇý(ÀÎÇÏÀÇ´ë)
±âŸ 11¿ù 14ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ (Room A) 17:00~17:10 Closing remarks ()